Abcam (ABC)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

1,345.00p
   
  • Change Today:
    -6.00p
  • 52 Week High: 1,530.00p
  • 52 Week Low: 1,016.00p
  • Currency: UK Pounds
  • Shares Issued: 216.17m
  • Volume: 156,141
  • Market Cap: £2,907.53m
  • RiskGrade: 172

Abcam Overview

Abcam is a producer and distributor of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in understanding health and disease.

Key Personnel

CEO: Alan Thomas Hirzel
CFO: Michael Baldock
Company Secretary: Marc Perkins
Deputy Chairman: Jonathan Simon Milner
Non-Executive Chairman: Peter Allen
Senior Independent Director: Louise Patten
Non-Executive Dir: Giles Kerr, Sue Harris, Mara G Aspinall

Contact Details

Address: Discovery Drive, Cambridge Biomedical Campus, Cambridge, United Kingdom , CB2 0AX
Phone: +44 (0)1223 696 000
Fax: +44 (0)1223 215 215
Website: http://www.abcam.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-ShareFTSE AIM 50FTSE AIM 100
ISIN: GB00B6774699

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Abcam Market Data

Currency UK Pounds
Share Price 1,345.00p
Change Today -6.00p
% Change -0.44 %
52 Week High 1,530.00p
52 Week Low 1,016.00p
Volume 156,141
Shares Issued 216.17m
Market Cap £2,907.53m
RiskGrade 172

Abcam Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
99.07% below the market average99.07% below the market average99.07% below the market average99.07% below the market average99.07% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
39.71% above the market average39.71% above the market average39.71% above the market average39.71% above the market average39.71% above the market average
12.28% below the sector average12.28% below the sector average12.28% below the sector average12.28% below the sector average12.28% below the sector average
Income
98.58% below the market average98.58% below the market average98.58% below the market average98.58% below the market average98.58% below the market average
80% below the sector average80% below the sector average80% below the sector average80% below the sector average80% below the sector average
Growth
7.31% above the market average7.31% above the market average7.31% above the market average7.31% above the market average7.31% above the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average

What The Brokers Say

Strong Buy 2
Buy 1
Neutral 3
Sell 0
Strong Sell 2
Total 8
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Abcam Dividends

  Latest Previous
  Interim Final
Ex-Div 19-Mar-20 07-Nov-19
Paid 17-Apr-20 29-Nov-19
Amount 3.55p 8.58p

Trades for 03-Jul-2020

Time Volume / Share Price
17:13 6,673 @ 1,348.04p
16:35 76,017 @ 1,345.00p
16:29 15 @ 1,343.00p
16:29 7 @ 1,343.00p
16:29 58 @ 1,343.00p

Abcam Key Personnel

CEO Alan Thomas Hirzel
CFO Michael Baldock

Top of Page